Article History
Received: 19 January 2024
Accepted: 15 April 2024
First Online: 5 May 2024
Declarations
:
: Ethan T. Willis: None. Judy E. Kim: Advisory Board/Consultant – Allergan, Amgen, Apellis, Bausch&Lomb, Clearside Biomedical, Coherus, Dutch Ophthalmic Research Center, Eyepoint, Genentech/Roche, Notal Vision, Outlook Therapeutics, Regeneron. Eric W. Schneider: Consultant – Apellis, Carl Zeiss Meditec, Notal Vision, Iveric Bio.
: This article is based on personal experiences and previously conducted studies and does not contain any studies with human participants or animals performed by any of the authors.